Under construction – not a live service
Sign in
Taking people in FranceNo phase

Brain Scan Scores and Recovery After Stroke in Adults

Studies whether brain scan scores predict recovery after clot-removal treatment for ischemic stroke.

Plain-language title generated from the registry record
Registry title: Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke

Key facts

Where
Gonesse, FranceSee the site

Where in France

  • Centre Hospitalier de GonesseGonesse, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Centre Hospitalier de Gonesse
Trial code
NCT07069452
Record updated
16 July 2025
Original description
This study, called TARGET-ASPECT, looks at patients who had a type of stroke called acute ischemic stroke and were treated with clot-busting medicine and a procedure to remove the clot. Even with these treatments, about half of patients don't fully recover. The study aims to see if certain brain imaging scores, especially when combined, can better predict how well patients will recover 90 days after their stroke and if their blood vessels reopen successfully. The study will include 152 patients and last about 9 months. The goal is to find easy and reliable tools that doctors can use to make better treatment decisions.Read full original descriptionShow less

TARGET-ASPECT (Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke)

This study, called TARGET-ASPECT, looks at patients who had a type of stroke called acute ischemic stroke and were treated with clot-busting medicine and a procedure to remove the clot. Even with these treatments, about half of patients don't fully recover. The study aims to see if certain brain imaging scores, especially when combined, can better predict how well patients will recover 90 days after their stroke and if their blood vessels reopen successfully. The study will include 152 patients and last about 9 months. The goal is to find easy and reliable tools that doctors can use to make better treatment decisions.

Inclusion: Patients aged 18 years or older; Confirmed acute ischemic stroke on imaging; Treated with both thrombolysis and thrombectomy; Clinical follow-up data available at 90 days (mRS score).

Exclusion: Primary hemorrhagic stroke; Early death or loss to follow-up without evaluation; Poor-quality imaging that cannot be analyzed.

ClinicalTrials.gov NCT07069452